IRD – opus genetics, inc. (US:NASDAQ)
Stock Stats
News
The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside [Yahoo! Finance]
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference
Opus Genetics (NASDAQ:IRD) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease
Form 8-K Opus Genetics, Inc. For: Dec 17
Form SCHEDULE 13D/A Opus Genetics, Inc. Filed by: Foundation Fighting Blindness Retinal Degeneration Fund
Form 4 Opus Genetics, Inc. For: Dec 09 Filed by: Foundation Fighting Blindness Retinal Degeneration Fund
Form 10-Q Opus Genetics, Inc. For: Sep 30
Form 8-K Opus Genetics, Inc. For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.